Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3B6F

Nucleosome core particle treated with cisplatin

3B6F の概要
エントリーDOI10.2210/pdb3b6f/pdb
関連するPDBエントリー1KX5 3B6G
分子名称147-MER DNA, Histone H3.2, Histone H4, ... (7 entities in total)
機能のキーワードnucleosome, chromatin, platinum adduct, cisplatin, anti-cancer, drug, acetylation, chromosomal protein, dna-binding, methylation, nucleosome core, nucleus, phosphorylation, ubl conjugation, structural protein-dna complex, structural protein/dna
由来する生物種Homo sapiens (human)
詳細
細胞内の位置Nucleus: P84233 P62799 P02281
Nucleus (By similarity): Q6AZJ8
タンパク質・核酸の鎖数10
化学式量合計199426.87
構造登録者
Wu, B.,Davey, C.A. (登録日: 2007-10-29, 公開日: 2007-12-25, 最終更新日: 2023-11-01)
主引用文献Wu, B.,Droge, P.,Davey, C.A.
Site selectivity of platinum anticancer therapeutics
Nat.Chem.Biol., 4:110-112, 2008
Cited by
PubMed Abstract: X-ray crystallographic and biochemical investigation of the reaction of cisplatin and oxaliplatin with nucleosome core particle and naked DNA reveals that histone octamer association can modulate DNA platination. Adduct formation also occurs at specific histone methionine residues, which could serve as a nuclear platinum reservoir influencing adduct transfer to DNA. Our findings suggest that the nucleosome center may provide a favorable target for the design of improved platinum anticancer drugs.
PubMed: 18157123
DOI: 10.1038/nchembio.2007.58
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (3.45 Å)
構造検証レポート
Validation report summary of 3b6f
検証レポート(詳細版)ダウンロードをダウンロード

250059

件を2026-03-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon